Intravenous form of omeprazole will be replaced by oral form in patients with ulcer bleeding
The results of the research suggest the same therapeutic efficacy of oral and intravenous forms of omeprazole in patients with peptic ulcer bleeding. This formulation should be administered at a high dose (orally first dose of 80 mg and then 40 mg every 12 hours). Use of oral omeprazole is more cost...
Main Author: | A.V. Savustyanenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaslavsky O.Yu.
2014-11-01
|
Series: | Gastroenterologìa |
Subjects: | |
Online Access: | http://gastro.zaslavsky.com.ua/article/view/82087 |
Similar Items
-
Electrolyte disturbances in children receiving omeprazole for gastroesophageal reflux disease
by: Fatemeh Famouri, et al.
Published: (2020-01-01) -
Effects of Omeprazole on Iron Absorption: Preliminary Study
by: Mahmut Yaşar Çeliker, et al.
Published: (2013-09-01) -
Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis
by: Liang Chih-Ming, et al.
Published: (2012-03-01) -
Ticagrelor and omeprazole: A desirable combination in post MI patients?
by: Dimitrios Alexopoulos
Published: (2020-09-01) -
Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy
by: Yen Hsu-Heng, et al.
Published: (2012-06-01)